Condition
Trop2
Total Trials
6
Recruiting
4
Active
5
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Recruiting4
Active Not Recruiting1
Not Yet Recruiting1
Clinical Trials (6)
Showing 6 of 6 trials
NCT07685197Phase 2Not Yet Recruiting
Comparative ¹⁸F-FDG and ⁶⁸Ga-MY6349 PET/CT Imaging for Assessing TROP2 ADC Therapeutic Efficacy in EGFR-TKI Resistant Advanced NSCLC
NCT07314255Active Not Recruiting
The Role of Trop2 in Radioactive Iodine-131 Therapy Sensitivity in Papillary Thyroid Carcinoma
NCT07251868Recruiting
Evaluation of Trop-2 ADC in Breast Cancer Patients With Brain Metastases: A Real-World Study
NCT07151898Recruiting
PET/CT for Trop2 ADC Response Evaluation NSCLC
NCT07046702Recruiting
68Ga-MY6349 PET/CT in Solid Tumors
NCT07046689Recruiting
PET/CT for Trop2 ADC Response Evaluation Cancers
Showing all 6 trials